Weak or partial agonism of ERα during long term estrogen deprivation drives unique mechanisms of estrogen-independent growth

被引:0
|
作者
Sikora, Matthew J. [1 ]
Johnson, Michael D. [2 ]
Rae, James M. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Georgetown Univ, Washington, DC USA
关键词
D O I
10.1158/1538-7445.AM2011-2293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2293
引用
收藏
页数:1
相关论文
共 22 条
  • [11] Gene expression changes during the development of estrogen-independent and anti-estrogen-resistant growth in breast cancer cell culture models (vol 20, pg 51, 2009)
    Pennanen, Pasi T.
    Savilinna, Nanna S.
    Ylikomi, Timo J.
    ANTI-CANCER DRUGS, 2009, 20 (10) : 956 - 956
  • [12] Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation
    Martin, LA
    Farmer, I
    Johnston, SRD
    Ali, S
    Dowsett, M
    ENDOCRINE-RELATED CANCER, 2005, 12 : S75 - S84
  • [13] miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
    Bacci, Marina
    Giannoni, Elisa
    Fearns, Antony
    Ribas, Ricardo
    Gao, Qiong
    Taddei, Maria Letizia
    Pintus, Gianfranco
    Dowsett, Mitch
    Isacke, Clare M.
    Martin, Lesley-Ann
    Chiarugi, Paola
    Morandi, Andrea
    CANCER RESEARCH, 2016, 76 (06) : 1615 - 1626
  • [14] The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
    Martin, LA
    Pancholi, S
    Farmer, I
    Johnston, SRD
    Dowsett, M
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S28 - S29
  • [15] The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
    L-A Martin
    S Pancholi
    I Farmer
    SRD Johnston
    M Dowsett
    Breast Cancer Research, 7
  • [16] The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation
    Sabnis, GJ
    Jelovac, D
    Long, B
    Brodie, A
    CANCER RESEARCH, 2005, 65 (09) : 3903 - 3910
  • [17] Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
    Santen, RJ
    Song, RX
    Zhang, Z
    Kumar, R
    Jeng, MH
    Masamura, A
    Lawrence, J
    Berstein, L
    Yue, W
    ENDOCRINE-RELATED CANCER, 2005, 12 : S61 - S73
  • [18] Antimitogenic effects of estradiol on vascular smooth muscle cell (SMC) growth are mediated via estrogen receptor (ER)-independent mechanisms and involve estradiol metabolism
    Barchiesi, F
    Gillespie, DG
    Jackson, EK
    Fingerle, J
    Dubey, RK
    HYPERTENSION, 2001, 38 (03) : 501 - 502
  • [19] Ethinylestradiol treatment downregulates ER and upregulates PgR; Immunohistochemical analysis in postmenopausal breast cancer tissues after prior long-term estrogen-deprivation therapy
    Iwase, Hirotaka
    Omoto, Yoko
    Takeshita, Takashi
    Yamamoto-Ibusuki, Mutsuko
    Hayashi, Mitsuhiro
    Sueta, Aiko
    Fujiwara, Saori
    Yamamoto, Yutaka
    CANCER RESEARCH, 2015, 75
  • [20] Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells
    Stephen, RL
    Shaw, LE
    Larsen, C
    Corcoran, D
    Darbre, PD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (43) : 40080 - 40086